Biogen Cash Flow Statement (2009-2026) | BIIB

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	991.20M	317.00M	-38.20M	221.80M	1,052.80M	1,134.90M	549.50M	387.60M	593.30M	-68.30M	248.90M	393.40M	583.60M	388.50M	266.70M	240.50M	634.80M	466.50M	-48.90M	319.50M
Depreciation and Depletion (Quarter)	54.70M	65.10M	66.60M	76.30M	67.20M	64.20M	64.70M	62.10M	64.50M	64.10M	63.50M	69.30M	71.90M	72.70M	72.80M	71.40M	66.90M	66.50M	68.00M	67.90M
Share-based Compensation (Quarter)	54.10M	55.70M	58.80M	67.60M	55.70M	63.60M	67.20M	75.60M	71.50M	62.20M	54.90M	72.80M	70.60M	72.70M	75.10M	81.00M	74.90M	75.30M	59.60M	84.00M
Deferred Taxes (Quarter)	-607.80M	-127.30M	323.30M	1.00M	-48.50M	-92.30M	-28.80M	-64.50M	-106.40M	-206.80M	71.90M	39.90M	-87.00M	-52.60M	-58.40M	-27.80M	-31.30M	253.80M	166.90M	23.60M
Gains from Investment Securities (Quarter)	-280.90M		-201.60M	20.80M	-9.30M	503.70M	-513.30M	-79.60M	134.20M		10.00M	46.90M		23.80M	-248.20M	-40.90M	13.20M	5.60M	14.40M	20.50M
Asset Writedowns and Impairment (Quarter)	191.60M	15.00M	120.00M	275.00M	45.00M	275.00M	275.00M	17.40M	19.40M		-62.10M	27.50M		20.20M	12.50M	7.30M	3.50M		52.90M	4.80M
Cash from Operations (Quarter)	1,227.30M	805.30M	838.30M	161.80M	736.50M	661.00M	-175.00M	455.30M	487.00M	592.40M	12.50M	553.20M	625.80M	935.60M	760.90M	259.30M	160.90M	1,272.50M	511.90M	645.50M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)											31.50M	44.10M	90.10M	50.90M	44.90M	51.40M	52.50M	61.50M	75.40M	107.60M
Depreciation & Amortization (CF) (Quarter)	117.20M	133.20M	134.70M	143.10M	134.80M	120.70M	119.80M	112.30M	117.40M	125.00M	140.10M	147.50M	158.90M	182.80M	184.00M	183.20M	194.30M	202.20M	200.20M	204.40M
Change in Working Capital
Change in Receivables (Quarter)	-174.30M	53.70M	-167.00M	87.50M	-20.20M	-64.30M	200.40M	-77.20M	55.40M	98.30M	-137.80M	-40.70M	28.40M	28.20M	-238.20M	-70.40M	240.90M	-158.70M	-114.50M	-103.40M
Change in Inventory (Quarter)	81.30M	128.80M	139.80M	142.60M	100.70M	95.00M	-18.10M	-27.90M	93.00M	-30.20M	96.00M	77.70M	110.50M	19.20M	66.40M	-62.00M	89.90M	7.40M	29.40M	-116.20M
Change in Accured Expenses (Quarter)	95.20M	-54.90M	98.80M	-461.60M	1,095.60M	-1.70M	-745.70M	-295.00M	167.90M	421.00M	-495.50M	-177.10M	61.50M	31.40M	-94.50M	-300.50M	-18.20M	286.00M	-215.30M	-243.20M
Change in Taxes (Quarter)	106.70M	89.00M	-29.70M	101.90M	-167.80M	-34.30M	-42.10M	65.00M	-147.40M	-32.40M	-184.20M	-2.20M	-5.50M	69.80M	16.40M	69.10M	-603.80M	-229.40M	-194.00M	18.40M
Other Working Capital Changes (Quarter)	16.40M	-9.70M	-88.80M	213.60M	-79.60M	-149.90M	34.90M	96.80M	-41.30M	15.90M	-66.80M	56.10M	46.90M	-37.30M	-37.60M	53.50M	22.00M	104.40M	-119.30M	89.00M
Investing Activities
Capital Expenditures (Quarter)	71.90M	42.00M	51.60M	57.90M	36.90M	59.10M	86.40M	66.60M	71.00M	74.20M	65.20M	45.90M	33.50M	35.00M	39.30M	37.10M	26.60M	46.20M	43.90M	51.20M
Sales of Property, Plant and Equipment (Quarter)		-28.10M	28.10M			603.00M	-582.60M							-14.40M
Change in Intangibles (Quarter)		1.90M	16.90M		1.90M		1.00M	5.00M	16.00M	13.40M		75.00M	9.10M	95.00M	15.00M	10.00M		5.30M	16.30M
Acquisitions (Quarter)											590.50M				-1074.80M
Divestments (Quarter)	-28.10M	28.10M	65.40M		990.30M		-990.30M				-668.50M				-262.10M				56.70M
Change in Acquisitions & Divestments (Quarter)	633.50M	-1361.50M	3,314.20M	543.60M	917.90M	1,643.20M	566.30M	406.70M	1,275.50M	5,698.60M		55.60M	1.90M	39.20M	-96.70M			56.60M	-33.60M	0.50M
Cash from Investing Activities (Quarter)	-152.70M	-233.60M	-112.70M	-648.00M	693.50M	1,672.20M	-141.10M	-953.00M	-753.50M	-1742.20M	-652.30M	-66.00M	466.50M	-1181.10M	-18.60M	-47.30M	-57.00M	-35.10M	-1231.70M	-209.50M
Financing Activities
Other financing activities (Quarter)	-31.90M	-74.30M	73.70M	4.10M	8.00M	0.10M	-17.80M	0.20M	1.50M	2.50M	-10.20M	7.30M	-1.30M	-12.60M	6.60M	1.30M	-1.20M	6.20M	-1.30M	11.30M
Cash from Financing Activities (Quarter)	-564.50M	-746.50M	9.80M	-16.50M	-471.50M	-1251.90M	-7.40M	-43.40M	-9.80M	848.60M	-646.10M	-439.60M	-245.20M	-6.60M	7.90M	-23.00M	-11.70M	-130.20M	-137.00M	-43.80M
Dividend Payments
Dividends Paid - Common (Quarter)
Additional items
Exchange Rate Effect (Quarter)	14.40M	-25.40M	-15.80M	-9.40M	-61.20M	-52.30M	67.20M	20.00M	-4.10M	-28.70M	47.90M	-23.10M	-12.60M	42.40M	-74.40M	34.30M	68.30M	-3.20M	2.50M	-18.00M
Change in Cash (Quarter)	510.10M	-174.80M	735.40M	-502.70M	958.50M	1,081.30M	-323.50M	-541.10M	-276.30M	-301.20M	-1285.90M	47.60M	847.10M	-252.10M	750.20M	189.00M	92.20M	1,107.20M	-856.80M	392.20M
Free Cash Flow (Quarter)	1,155.40M	763.30M	786.70M	103.90M	699.60M	601.90M	-261.40M	388.70M	416.00M	518.20M	-52.70M	507.30M	592.30M	900.60M	721.60M	222.20M	134.30M	1,226.30M	468.00M	594.30M
Net Cash Flow (Quarter)	510.10M	-174.80M	735.40M	-502.70M	958.50M	1,081.30M	-323.50M	-541.10M	-276.30M	-301.20M	-1285.90M	47.60M	847.10M	-252.10M	750.20M	189.00M	92.20M	1,107.20M	-856.80M	392.20M

Research Tools

Biogen Cash Flow Statement (2009-2026) | BIIB

Create an account

Sign In

Reset Password